Gary Hattersley
CIK 1521111 · CHIEF SCIENTIFIC OFFICER · last filed 2026-03-03
Gary Hattersley is a CHIEF SCIENTIFIC OFFICER who has filed 21 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for NUVB, was dated Mar 3, 2026. Across all open-market trades the lifetime net is −$5.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
21
-$5.36M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUVB | CHIEF SCIENTIFIC OFFICER | — | $6.70 | — | $0 | 1 | 2026-03-03 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | CHIEF SCIENTIFIC OFFICER | 0 | $0.01 | $0 | -$3.17M | 8 | 2025-11-24 |
| Radius Health, Inc. (RDUS) Delisted | Chief Scientific Officer | 0 | $30.00 | $0 | -$2.19M | 8 | 2018-02-15 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | NUVB | Grant (A) | — | $0 | EDGAR |
| 2025-11-24 | Nuvation Bio Inc. (NUVB.WS) Delisted | Mixed | — | -$1.96M | EDGAR |
| 2025-11-20 | NUVB | Notice (144) | −369,051 | -$2.67M | EDGAR |
| 2025-10-29 | Nuvation Bio Inc. (NUVB.WS) Delisted | Mixed | — | -$328.5K | EDGAR |
| 2025-10-27 | NUVB | Notice (144) | −100,000 | -$485.0K | EDGAR |
| 2025-03-04 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-04 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-02 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-31 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-02 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.